Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 GLOBAL SILDENAFIL CITRATE MARKET, BY APPLICATION

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. MEDICAL USES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Sexual dysfunction

4.2.4.1. Market size and forecast

4.2.5. Pulmonary hypertension

4.2.5.1. Market size and forecast

4.2.6. Altitude sickness

4.2.6.1. Market size and forecast

4.2.7. Raynaud ’s phenomenon

4.2.7.1. Market size and forecast

4.3. NON MEDICAL USES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

Chapter: 5 GLOBAL SILDENAFIL CITRATE MARKET, BY REGION

5.1. OVERVIEW
5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast

5.2.3.1. U.S. market size and forecast
5.2.3.2. Canada market size and forecast
5.2.3.3. Mexico market size and forecast

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.4. Market size and forecast

5.3.4.1. Germany market size and forecast
5.3.4.2. France market size and forecast
5.3.4.3. UK market size and forecast
5.3.4.4. Italy market size and forecast
5.3.4.5. Spain market size and forecast
5.3.4.6. Rest of Europe market size and forecast

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast

5.4.3.1. Japan market size and forecast
5.4.3.2. China market size and forecast
5.4.3.3. India market size and forecast
5.4.3.4. Rest of Asia-Pacific market size and forecast

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast

5.5.3.1. Brazil market size and forecast
5.5.3.2. Saudi Arabia market size and forecast
5.5.3.3. South Africa market size and forecast
5.5.3.4. Rest of LAMEA market size and forecast

Chapter: 6 COMPANY PROFILES

6.1. AGLOWMED PHARMACEUTICALS LTD.

6.1.1. Operating business segments
6.1.2. Business performance
6.1.3. Key strategic moves and developments

6.2. WISDOM PHARMACEUTICAL CO.,LTD

6.2.1. Operating business segments
6.2.2. Business performance
6.2.3. Key strategic moves and developments

6.3. IND-SWIFT LIMITED

6.3.1. Operating business segments
6.3.2. Business performance
6.3.3. Key strategic moves and developments

6.4. H.L.HEALTHCARE PVT. LTD.

6.4.1. Operating business segments
6.4.2. Business performance
6.4.3. Key strategic moves and developments

6.5. ALEMBIC CHEMICAL WORKS CO. LTD

6.5.1. Operating business segments
6.5.2. Business performance
6.5.3. Key strategic moves and developments

6.6. TORRENT PHARMACEUTICALS LTD

6.6.1. Operating business segments
6.6.2. Business performance
6.6.3. Key strategic moves and developments

6.7. ATLAS LABORATORIES PVT LTD

6.7.1. Operating business segments
6.7.2. Business performance
6.7.3. Key strategic moves and developments

6.8. RANBAXY LABORATORIES LTD.

6.8.1. Operating business segments
6.8.2. Business performance
6.8.3. Key strategic moves and developments

6.9. SUN RISE INTERNATIONAL LABS LTD

6.9.1. Operating business segments
6.9.2. Business performance
6.9.3. Key strategic moves and developments

6.10. LUPIN LABORATORIES LTD.

6.10.1. Operating business segments
6.10.2. Business performance
6.10.3. Key strategic moves and developments